forecasted federal funding opportunity

Critical Path Public Private Partnerships Clinical Trials Optional

The FDA seeks an application to continue to maintain, manage existing consortia groups convened and established by the Critical Path Institute. This is a renewal of the cooperative agreement #5U18FD005320 as part of the Critical Path Initiative. This is in support of Critical Path Initiative introduced in Section 56…

Agency

Food and Drug Administration

Opportunity number

FOR-FD-24-012